05 Dec 2017 – Start of Phase Ia clinical trial with single ascending dose The trial is divided into 4 investigation panels.
24 Apr 2017 – The Bill & Melinda Gates Foundation has awarded $2.45M to take our PBTZ169 into clinical trials
05 Dec 2017 – Start of Phase Ia clinical trial with single ascending dose The trial is divided into 4 investigation panels.
24 Apr 2017 – The Bill & Melinda Gates Foundation has awarded $2.45M to take our PBTZ169 into clinical trials